Carcinoid Syndrome clinical trials

Explore recruiting carcinoid syndrome clinical trials.

Recruiting carcinoid syndrome studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Carcinoid Syndrome trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Randomized, Parallel Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Paltusotine in Adults with Carcinoid Syndrome due to Well-Differentiated Neuroendocrine Tumors (CAREFNDR)

France, Italy, Spain, Poland, Belgium, Germany +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Randomized, Parallel Group Study to Evaluate the Safety, Pharmacokinetics, and Dose Response of Paltusotine Treatment in Subjects with Carcinoid Syndrome

Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Carcinoid Syndrome trials by city

Carcinoid Syndrome in Toronto Carcinoid Syndrome in Vancouver Carcinoid Syndrome in Montreal Carcinoid Syndrome in Calgary Carcinoid Syndrome in Edmonton Carcinoid Syndrome in Ottawa Carcinoid Syndrome in Winnipeg Carcinoid Syndrome in Quebec City Carcinoid Syndrome in Hamilton Carcinoid Syndrome in Kitchener Carcinoid Syndrome in London Carcinoid Syndrome in Halifax Carcinoid Syndrome in New York Carcinoid Syndrome in Los Angeles Carcinoid Syndrome in Chicago Carcinoid Syndrome in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease